The Diabetes Dilemma for Statin Users | Eric Topol
WEBMar 4, 2012 · We’re overdosing on cholesterol-lowering statins, and the consequence could be a sharp increase in the incidence of Type 2 diabetes. This past week, the Food and Drug Administration raised questions about the side effects of these drugs and developed new labels for these medications that will now warn of …
The Diabetes Dilemma for Statin Users - The New York Times
WEBMar 5, 2012 · By Eric J. Topol. March 4, 2012. Share full article. San Diego, Calif. We’re overdosing on cholesterol-lowering statins, and the consequence could be a sharp increase in the incidence of Type 2...
Top Cardiologist Argues We Should Dial Back On Statins Because …
WEBMar 5, 2012 · Eric Topol, a well-known cardiologist and professor of genomics at Scripps Research Institute, has broken ranks with many other heart doctors tonight with a New York Times Op-Ed in which he...
Scripps Cardiologist Discusses Statin Prescription Guidelines
WEBEric Topol, MD, cardiologist and chief academic officer at Scripps Health. Controversy has followed new guidelines for prescribing statin drugs for lowering cholesterol ever since the recommendations were released in November by the American College of Cardiology and the American Heart Association.
Dr. Topol Discusses Statins and Diabetes Risk - Scripps Health
WEBWhile a new study concluded that the heart-disease prevention benefits outweigh the diabetes risk, Scripps Clinic cardiologist Eric Topol, M.D., continues to warn against over prescribing the popular drugs.
Pradeep Natarajan: Preventing Heart Disease - by Eric Topol
WEBAug 13, 2024 · I'm Eric Topol and with me is Pradeep Natarajan from Harvard. He's Director of Preventative Cardiology at the Mass General Brigham Health System and he has been lighting it up on the field of cardiovascular.
Eric Topol - Wikipedia
WEBEric Jeffrey Topol (born June 26, 1954 (age 70)) [1] is an American cardiologist, scientist, and author. He is the founder and director of the Scripps Research Translational Institute, [2] a professor of Molecular Medicine and Executive Vice-President at Scripps Research Institute, and a senior consultant at the Division of Cardiovascular ...
Statins and Diabetes -- Is There Really a Risk? - Forbes
WEBMar 5, 2012 · Topol accurately states the results on which this label change was based. The pooling of multiple clinical studies for more than 90,000 patients randomly assigned to take either statins or...
Can Statins Cause Diabetes? - The New York Times
WEBJul 22, 2016 · The higher the dose of a statin, the greater the diabetes risk, said Dr. Eric Topol, director of the Scripps Translational Science Institute and chief academic officer at Scripps Health.
Statins and Diabetes: Real Concern or Much Ado About Nothing? - Forbes
WEBMar 5, 2012 · Topol focuses on the new warning that statins raise the risk of diabetes. He opens with a provocative statement: We’re overdosing on cholesterol-lowering statins, and the consequence...